| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0093-7754(01)90290-8 |
| P698 | PubMed publication ID | 11706404 |
| P50 | author | Gordon B. Mills | Q28086262 |
| P2093 | author name string | H Wang | |
| M Mao | |||
| X Fang | |||
| Y Lu | |||
| J Gray | |||
| R Jaffe | |||
| K W Cheng | |||
| A Eder | |||
| D Stokoe | |||
| K Siminovitch | |||
| R Swaby | |||
| P433 | issue | 5 Suppl 16 | |
| P304 | page(s) | 125-141 | |
| P577 | publication date | 2001-10-01 | |
| P1433 | published in | Seminars in Oncology | Q14330412 |
| P1476 | title | The role of genetic abnormalities of PTEN and the phosphatidylinositol 3-kinase pathway in breast and ovarian tumorigenesis, prognosis, and therapy | |
| P478 | volume | 28 |
| Q39979475 | A chemical screen in diverse breast cancer cell lines reveals genetic enhancers and suppressors of sensitivity to PI3K isoform-selective inhibition. |
| Q35857357 | A new crucial protein interaction element that targets the adenovirus E4-ORF1 oncoprotein to membrane vesicles |
| Q90248645 | AKT isoform-specific expression and activation across cancer lineages |
| Q38134714 | AKT-independent PI3-K signaling in cancer - emerging role for SGK3. |
| Q36127308 | AXL is an essential factor and therapeutic target for metastatic ovarian cancer |
| Q44329393 | Allelic imbalance and altered expression of genes in chromosome 2q11-2q16 from rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine |
| Q35777532 | Analysis of molecular aberrations in ovarian cancer allows novel target identification |
| Q36226739 | Apoptotic pathways and therapy resistance in human malignancies |
| Q33716992 | Association between PTEN Gene IVS4 polymorphism and risk of cancer: a meta-analysis |
| Q37148279 | BRCC2 inhibits breast cancer cell growth and metastasis in vitro and in vivo via downregulating AKT pathway |
| Q34356308 | Beta-parvin inhibits integrin-linked kinase signaling and is downregulated in breast cancer |
| Q35084316 | Breast cancer as a model of realistic challenges in pharmacogenomics |
| Q40399380 | Chemokine receptor 7 activates phosphoinositide-3 kinase-mediated invasive and prosurvival pathways in head and neck cancer cells independent of EGFR. |
| Q36785958 | Chemosensitisation by manganese superoxide dismutase inhibition is caspase-9 dependent and involves extracellular signal-regulated kinase 1/2. |
| Q28566685 | Critical role of PTEN in the coupling between PI3K/Akt and JNK1/2 signaling in ischemic brain injury |
| Q40074140 | Differential role of gonadotropin-releasing hormone on human ovarian epithelial cancer cell invasion. |
| Q35577444 | Drug resistance reversal--are we getting closer? |
| Q24795054 | Essential function for ErbB3 in breast cancer proliferation |
| Q35918889 | Estradiol abrogates apoptosis in breast cancer cells through inactivation of BAD: Ras-dependent nongenomic pathways requiring signaling through ERK and Akt |
| Q47988949 | Evaluation of techniques using amplified nucleic acid probes for gene expression profiling |
| Q34160782 | Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma |
| Q33511864 | Expression profiling identifies genes involved in neoplastic transformation of serous ovarian cancer |
| Q28207468 | FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines |
| Q35032772 | Frequent genetic abnormalities of the PI3K/AKT pathway in primary ovarian cancer predict patient outcome |
| Q35024049 | Global deletion of Trp53 reverts ovarian tumor phenotype of the germ cell-deficient white spotting variant (Wv) mice |
| Q45258101 | Gonadotropins regulate N-cadherin-mediated human ovarian surface epithelial cell survival at both post-translational and transcriptional levels through a cyclic AMP/protein kinase A pathway |
| Q44306520 | HER2 Ile655Val and PTEN IVS4 polymorphisms in patients with breast cancer. |
| Q24810517 | Increased level of phosphorylated akt measured by chemiluminescence-linked immunosorbent assay is a predictor of poor prognosis in primary breast cancer overexpressing ErbB-2. |
| Q35754252 | Inhibition of cell growth and induction of apoptosis in ovarian carcinoma cell lines CaOV3 and SKOV3 by natural withanolide Withaferin A |
| Q40615155 | Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias |
| Q81634756 | Lineage infidelity of epithelial ovarian cancers is controlled by HOX genes that specify regional identity in the reproductive tract |
| Q33942901 | Linking molecular therapeutics to molecular diagnostics: inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells in vitro and in vivo |
| Q24806542 | New targets for therapy in breast cancer: mammalian target of rapamycin (mTOR) antagonists |
| Q35968752 | Novel agents in epithelial ovarian cancer |
| Q39425843 | PI3K/AKT pathway regulates phosphorylation of steroid receptors, hormone independence and tumor differentiation in breast cancer |
| Q28217868 | PTEN associates with the vault particles in HeLa cells |
| Q33423777 | Phase I study of the mTOR inhibitor ridaforolimus and the HDAC inhibitor vorinostat in advanced renal cell carcinoma and other solid tumors |
| Q40274520 | Potentiation of paclitaxel activity by the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin in human ovarian carcinoma cell lines with high levels of activated AKT. |
| Q35741627 | Prognostic significance of clinical factors and Akt activation in patients with bronchioloalveolar carcinoma |
| Q40527076 | Progressive changes in Met-dependent signaling in a human ovarian surface epithelial model of malignant transformation. |
| Q38236498 | Rab proteins: the key regulators of intracellular vesicle transport |
| Q96348276 | Regulating tumor suppressor genes: post-translational modifications |
| Q34866669 | Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase/Akt pathway. |
| Q36410968 | Selective PDZ protein-dependent stimulation of phosphatidylinositol 3-kinase by the adenovirus E4-ORF1 oncoprotein |
| Q36015852 | Systematic Analysis of Gene Expression Alterations and Clinical Outcomes for Long-Chain Acyl-Coenzyme A Synthetase Family in Cancer |
| Q35583942 | Targeting signal transduction pathways in metastatic breast cancer: a comprehensive review |
| Q24645461 | Targeting the mammalian target of rapamycin (mTOR): a new approach to treating cancer |
| Q34481735 | The Akt inhibitor KP372-1 inhibits proliferation and induces apoptosis and anoikis in squamous cell carcinoma of the head and neck. |
| Q24678674 | The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation |
| Q34825957 | The PTEN, Mdm2, p53 tumor suppressor-oncoprotein network |
| Q24308778 | The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers |
| Q64064411 | The Signal Transducer and Activator of Transcription 5B (STAT5B) Gene Promotes Proliferation and Drug Resistance of Human Mantle Cell Lymphoma Cells by Activating the Akt Signaling Pathway |
| Q35120347 | The effect of leucine restriction on Akt/mTOR signaling in breast cancer cell lines in vitro and in vivo |
| Q37187508 | Ubiquitin-specific protease 4 inhibits breast cancer cell growth through the upregulation of PDCD4 |
| Q33339736 | Vav3 oncogene activates estrogen receptor and its overexpression may be involved in human breast cancer |
Search more.